[ Price : $8.95]
FDA grants an orphan drug designation to Seattle Genetics Adcetris (brentuximab vedotin) for treating mycosis fungoides.[ Price : $8.95]
FDA releases the FDA-483 from a New England District Office 2012 inspection at Alaunus Pharmaceuticals, associated with New Englan...[ Price : $8.95]
Federal Register Notice: FDA plans a pubic hearing 12/12-13 to discuss microbial contamination of patient preoperative skin prepar...[ Price : $8.95]
CDERs Office of Prescription Drug Promotion notifies Alcon that a professional sales aid for its Patanase overstates the drugs eff...[ Price : $8.95]
FDA releases the FDA-483 reports from inspections at St. Jude Medical facilities in Puerto Rico and California.[ Price : $8.95]
Reuters reports that it took FDA 684 days to issue a Warning Letter after it has inspected the troubled New England Compounding Ce...[ Price : $8.95]
FDA grants OxiGene an orphan drug designation for OXi4503 for treating acute myelogenous leukemia.[ Price : $8.95]
FDA approves a HeartWare PMA for its HeartWare Ventricular Assist System, a left ventricular assist device intended for use to sup...